This study indicates a radiosensitization of two radioresistant tumor models, B16F10 melanoma and TS/A carcinoma, expressing high and low levels of MCAM, after silencing MCAM using the GET of pMCAM that was more pronounced in melanoma than in carcinoma. The gene discussed is MCAM; the disease is neoplasm.